Insulin biosimilar (Development Center for Biotechnology)
胰岛素生物类似药 (Development Center for Biotechnology)
Report date: 2022/01/14 13:23:58
Base Information
Drug NameInsulin biosimilar (Development Center for Biotechnology)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesDevelopment Center for Biotechnology
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesDevelopment Center for Biotechnology
Active IndicationsN/A
Inactive Indications
Other Information
ATC Code +[5]
Related LinksN/A